Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,issuanceOfStock,effectOfExchangeRate,WC,language,region,quoteType,triggerable,quoteSourceName,currency,priceHint,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,shortName,marketState,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,PFE.DE,-9145000000,5597689856,2011000000,,5682000000,245000000,4877000000,2385000000,10410000000,5142000000,5142000000,,-336000000,,,,805000000,14582000000,9440000000,4172000000,540000000,9000000,4877000000,4877000000,27974000000,89002000000,89953000000,68620000000,12591000000,158818000000,472000000,4085000000,95158000000,27954000000,49791000000,-116012000000,7260000000,1768000000,26652000000,2537000000,3676000000,-4663000000,14011000000,39533000000,20249000000,11899000000,13283000000,35347000000,8493000000,4064000000,-1356000000.0,0.0,-1747000000.0,-25000000.0,-2807000000.0,-1327000000.0,-15000000.0,4538000000.0,1216000000.0,163000000.0,-2172000000.0,-610000000.0,-228000000.0,-554000000.0,,,12881000000,en-US,US,EQUITY,False,Delayed Quote,EUR,2,GER,39.0,1630579195,0.46500015,38.62,39.105,38.62,27137,0,PFIZER INC,REGULAR,de_market,1.2066956,38.62 - 39.105,38.535,38.985,39.0,0,0,finmb_162270,XETRA,Pfizer Inc.,USD,80339,140803,11.48,0.41715115,27.52 - 44.265,-5.2649994,-0.11894272,27.52,44.265,1620110700,1635165000,1635510600,1.53,23.5792,0.039704163,0.019699268,33.09007,5.909931,0.17860135,1.654,12.267,38.24657,0.7534294,218488913920,3.1792614,15,Europe/Berlin,CEST,7200000,False,False,0.67,,,44.26,27.52,38.25,33.09,80.34k,140.8k,5.6B,,5.59B,0.04%,66.60%,,,,,,1.31,3.97%,1.53,3.97%,3.62,92.17%,,"Jul 29, 2021",,,"Dec 31, 2020","Apr 04, 2021",24.00%,25.80%,4.60%,14.03%,46.41B,8.34,44.60%,33.33B,16.82B,9.38B,1.65,45.40%,13.67B,2.44,39.7B,57.65,1.48,12.27,15.81B,12.38B,Value,10017,Healthcare,78500,1,5,"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.",New York,212 733 2323,NY,1,1609372800,1625011200,6,United States,http://www.pfizer.com,86400,2,235 East 42nd Street,Drug Manufacturersâ€”General
t-1,PFE.DE,-14810000000,5597689856,2828000000,,178000000,235000000,594000000,3481000000,8797000000,1632000000,1632000000,,-347000000,,,,-170000000,11684000000,10052000000,2887000000,-1454000000,257000000,348000000,594000000,28471000000,88674000000,90756000000,63238000000,12076000000,154229000000,470000000,3588000000,96770000000,26589000000,49577000000,-122676000000,5442000000,1784000000,25920000000,900000000,2002000000,-11688000000,15293000000,35067000000,20379000000,10437000000,11194000000,37133000000,8046000000,4309000000,-1356000000.0,0.0,-1747000000.0,-25000000.0,-2807000000.0,-1327000000.0,-15000000.0,4538000000.0,1216000000.0,163000000.0,-2172000000.0,-610000000.0,-228000000.0,-554000000.0,,,9147000000,en-US,US,EQUITY,False,Delayed Quote,EUR,2,GER,39.0,1630579195,0.46500015,38.62,39.105,38.62,27137,0,PFIZER INC,REGULAR,de_market,1.2066956,38.62 - 39.105,38.535,38.985,39.0,0,0,finmb_162270,XETRA,Pfizer Inc.,USD,80339,140803,11.48,0.41715115,27.52 - 44.265,-5.2649994,-0.11894272,27.52,44.265,1620110700,1635165000,1635510600,1.53,23.5792,0.039704163,0.019699268,33.09007,5.909931,0.17860135,1.654,12.267,38.24657,0.7534294,218488913920,3.1792614,15,Europe/Berlin,CEST,7200000,False,False,0.67,,,44.26,27.52,38.25,33.09,80.34k,140.8k,5.6B,,5.59B,0.04%,66.60%,,,,,,1.31,3.97%,1.53,3.97%,3.62,92.17%,,"Jul 29, 2021",,,"Dec 31, 2020","Apr 04, 2021",24.00%,25.80%,4.60%,14.03%,46.41B,8.34,44.60%,33.33B,16.82B,9.38B,1.65,45.40%,13.67B,2.44,39.7B,57.65,1.48,12.27,15.81B,12.38B,Value,10017,Healthcare,78500,1,5,"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.",New York,212 733 2323,NY,1,1609372800,1625011200,6,United States,http://www.pfizer.com,86400,2,235 East 42nd Street,Drug Manufacturersâ€”General
t-2,PFE.DE,-25570000000,5597689856,2352000000,,2176000000,236000000,2194000000,2923000000,9634000000,3461000000,3461000000,,-416000000,,,,-26000000,12131000000,8670000000,2497000000,-1285000000,257000000,2202000000,2194000000,30927000000,88161000000,113488000000,65259000000,10382000000,178983000000,470000000,13917000000,100284000000,29549000000,59902000000,-123656000000,6873000000,1587000000,34154000000,2649000000,2149000000,-12676000000,14403000000,47739000000,19139000000,8912000000,14012000000,49785000000,9295000000,4141000000,838000000.0,0.0,481000000.0,-618000000.0,-2821000000.0,-851000000.0,-218000000.0,2090000000.0,1258000000.0,173000000.0,-2172000000.0,-2251000000.0,-511000000.0,-525000000.0,48000000.0,31000000.0,13585000000,en-US,US,EQUITY,False,Delayed Quote,EUR,2,GER,39.0,1630579195,0.46500015,38.62,39.105,38.62,27137,0,PFIZER INC,REGULAR,de_market,1.2066956,38.62 - 39.105,38.535,38.985,39.0,0,0,finmb_162270,XETRA,Pfizer Inc.,USD,80339,140803,11.48,0.41715115,27.52 - 44.265,-5.2649994,-0.11894272,27.52,44.265,1620110700,1635165000,1635510600,1.53,23.5792,0.039704163,0.019699268,33.09007,5.909931,0.17860135,1.654,12.267,38.24657,0.7534294,218488913920,3.1792614,15,Europe/Berlin,CEST,7200000,False,False,0.67,,,44.26,27.52,38.25,33.09,80.34k,140.8k,5.6B,,5.59B,0.04%,66.60%,,,,,,1.31,3.97%,1.53,3.97%,3.62,92.17%,,"Jul 29, 2021",,,"Dec 31, 2020","Apr 04, 2021",24.00%,25.80%,4.60%,14.03%,46.41B,8.34,44.60%,33.33B,16.82B,9.38B,1.65,45.40%,13.67B,2.44,39.7B,57.65,1.48,12.27,15.81B,12.38B,Value,10017,Healthcare,78500,1,5,"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.",New York,212 733 2323,NY,1,1609372800,1625011200,6,United States,http://www.pfizer.com,86400,2,235 East 42nd Street,Drug Manufacturersâ€”General
t-3,PFE.DE,-27654000000,5597689856,1894000000,,3953000000,228000000,3426000000,2696000000,9569000000,4074000000,4074000000,,-372000000,,,,519000000,11801000000,7727000000,2232000000,-121000000,257000000,3434000000,3426000000,33541000000,87886000000,113370000000,64336000000,9939000000,177934000000,470000000,13907000000,100203000000,30118000000,58449000000,-124223000000,6547000000,1801000000,32723000000,2360000000,1481000000,-13245000000,14113000000,46424000000,18860000000,9581000000,12554000000,50529000000,8564000000,3872000000,-12547000000.0,0.0,-13011000000.0,11320000000.0,9159000000.0,-648000000.0,-351000000.0,3555000000.0,1245000000.0,16000000.0,-2111000000.0,-84000000.0,-469000000.0,-479000000.0,34000000.0,-55000000.0,13701000000,en-US,US,EQUITY,False,Delayed Quote,EUR,2,GER,39.0,1630579195,0.46500015,38.62,39.105,38.62,27137,0,PFIZER INC,REGULAR,de_market,1.2066956,38.62 - 39.105,38.535,38.985,39.0,0,0,finmb_162270,XETRA,Pfizer Inc.,USD,80339,140803,11.48,0.41715115,27.52 - 44.265,-5.2649994,-0.11894272,27.52,44.265,1620110700,1635165000,1635510600,1.53,23.5792,0.039704163,0.019699268,33.09007,5.909931,0.17860135,1.654,12.267,38.24657,0.7534294,218488913920,3.1792614,15,Europe/Berlin,CEST,7200000,False,False,0.67,,,44.26,27.52,38.25,33.09,80.34k,140.8k,5.6B,,5.59B,0.04%,66.60%,,,,,,1.31,3.97%,1.53,3.97%,3.62,92.17%,,"Jul 29, 2021",,,"Dec 31, 2020","Apr 04, 2021",24.00%,25.80%,4.60%,14.03%,46.41B,8.34,44.60%,33.33B,16.82B,9.38B,1.65,45.40%,13.67B,2.44,39.7B,57.65,1.48,12.27,15.81B,12.38B,Value,10017,Healthcare,78500,1,5,"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.",New York,212 733 2323,NY,1,1609372800,1625011200,6,United States,http://www.pfizer.com,86400,2,235 East 42nd Street,Drug Manufacturersâ€”General
